Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HESX1
|
ENSG00000163666.4 | HESX homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HESX1 | hg19_v2_chr3_-_57233966_57234014 | -0.18 | 3.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_90198535 | 9.32 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr2_-_89310012 | 8.96 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr2_-_89292422 | 8.55 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr14_-_106406090 | 8.49 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr2_-_89513402 | 8.02 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr2_+_90229045 | 7.89 |
ENST00000390278.2
|
IGKV1D-42
|
immunoglobulin kappa variable 1D-42 (non-functional) |
chr2_+_89952792 | 7.82 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
chr2_+_90259593 | 7.54 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr2_-_89568263 | 7.50 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
chr2_-_89399845 | 7.12 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr2_-_89340242 | 6.70 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr2_+_90192768 | 6.22 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr2_-_89247338 | 6.19 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr2_+_114163945 | 5.73 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr2_+_90248739 | 5.09 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
chr2_+_90458201 | 5.03 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
chr16_+_56995762 | 3.48 |
ENST00000200676.3
ENST00000379780.2 |
CETP
|
cholesteryl ester transfer protein, plasma |
chr17_-_31404 | 3.32 |
ENST00000343572.7
|
DOC2B
|
double C2-like domains, beta |
chr11_+_67222818 | 2.70 |
ENST00000325656.5
|
CABP4
|
calcium binding protein 4 |
chr11_-_5276008 | 2.62 |
ENST00000336906.4
|
HBG2
|
hemoglobin, gamma G |
chr1_-_203320617 | 2.56 |
ENST00000354955.4
|
FMOD
|
fibromodulin |
chr1_+_159175201 | 2.49 |
ENST00000368121.2
|
DARC
|
Duffy blood group, atypical chemokine receptor |
chrX_+_135730297 | 2.47 |
ENST00000370629.2
|
CD40LG
|
CD40 ligand |
chr14_-_91884150 | 2.46 |
ENST00000553403.1
|
CCDC88C
|
coiled-coil domain containing 88C |
chr3_+_14860469 | 2.43 |
ENST00000285046.5
|
FGD5
|
FYVE, RhoGEF and PH domain containing 5 |
chr16_+_215965 | 2.27 |
ENST00000356815.3
|
HBM
|
hemoglobin, mu |
chr6_-_46703069 | 2.24 |
ENST00000538237.1
ENST00000274793.7 |
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
chr7_+_130126165 | 2.23 |
ENST00000427521.1
ENST00000416162.2 ENST00000378576.4 |
MEST
|
mesoderm specific transcript |
chr16_+_56995854 | 2.03 |
ENST00000566128.1
|
CETP
|
cholesteryl ester transfer protein, plasma |
chr1_+_45265897 | 2.02 |
ENST00000372201.4
|
PLK3
|
polo-like kinase 3 |
chr2_-_197036289 | 1.98 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
chrX_+_135730373 | 1.93 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
chr5_+_40679584 | 1.91 |
ENST00000302472.3
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4) |
chr19_+_42082506 | 1.87 |
ENST00000187608.9
ENST00000401445.2 |
CEACAM21
|
carcinoembryonic antigen-related cell adhesion molecule 21 |
chr6_+_26273144 | 1.76 |
ENST00000377733.2
|
HIST1H2BI
|
histone cluster 1, H2bi |
chr14_-_106068065 | 1.74 |
ENST00000390541.2
|
IGHE
|
immunoglobulin heavy constant epsilon |
chr12_-_55367361 | 1.70 |
ENST00000532804.1
ENST00000531122.1 ENST00000533446.1 |
TESPA1
|
thymocyte expressed, positive selection associated 1 |
chr2_-_1748214 | 1.66 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr11_+_50257784 | 1.63 |
ENST00000529219.1
|
RP11-347H15.4
|
RP11-347H15.4 |
chr8_-_16035454 | 1.55 |
ENST00000355282.2
|
MSR1
|
macrophage scavenger receptor 1 |
chr19_-_45579762 | 1.50 |
ENST00000303809.2
|
ZNF296
|
zinc finger protein 296 |
chr19_-_19739321 | 1.47 |
ENST00000588461.1
|
LPAR2
|
lysophosphatidic acid receptor 2 |
chr4_-_144826682 | 1.44 |
ENST00000358615.4
ENST00000437468.2 |
GYPE
|
glycophorin E (MNS blood group) |
chr19_+_42388437 | 1.43 |
ENST00000378152.4
ENST00000337665.4 |
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1 |
chr19_+_41698927 | 1.41 |
ENST00000310054.4
|
CYP2S1
|
cytochrome P450, family 2, subfamily S, polypeptide 1 |
chr1_-_20446020 | 1.24 |
ENST00000375105.3
|
PLA2G2D
|
phospholipase A2, group IID |
chr14_+_78227105 | 1.19 |
ENST00000439131.2
ENST00000355883.3 ENST00000557011.1 ENST00000556047.1 |
C14orf178
|
chromosome 14 open reading frame 178 |
chr19_+_45312310 | 1.13 |
ENST00000589651.1
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group) |
chr19_+_41699135 | 1.11 |
ENST00000542619.1
ENST00000600561.1 |
CYP2S1
|
cytochrome P450, family 2, subfamily S, polypeptide 1 |
chr12_-_55367331 | 1.09 |
ENST00000526532.1
ENST00000532757.1 |
TESPA1
|
thymocyte expressed, positive selection associated 1 |
chr14_-_25103472 | 1.09 |
ENST00000216341.4
ENST00000382542.1 ENST00000382540.1 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr10_+_90672113 | 1.07 |
ENST00000371922.1
|
STAMBPL1
|
STAM binding protein-like 1 |
chr1_+_19967014 | 1.06 |
ENST00000428975.1
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
chr6_+_31939608 | 1.06 |
ENST00000375331.2
ENST00000375333.2 |
STK19
|
serine/threonine kinase 19 |
chr8_+_124084899 | 1.03 |
ENST00000287380.1
ENST00000309336.3 ENST00000519418.1 ENST00000327098.5 ENST00000522420.1 ENST00000521676.1 ENST00000378080.2 |
TBC1D31
|
TBC1 domain family, member 31 |
chr5_+_149340282 | 1.02 |
ENST00000286298.4
|
SLC26A2
|
solute carrier family 26 (anion exchanger), member 2 |
chr17_+_47572647 | 1.00 |
ENST00000172229.3
|
NGFR
|
nerve growth factor receptor |
chr1_-_205290865 | 1.00 |
ENST00000367157.3
|
NUAK2
|
NUAK family, SNF1-like kinase, 2 |
chr19_+_45312347 | 0.99 |
ENST00000270233.6
ENST00000591520.1 |
BCAM
|
basal cell adhesion molecule (Lutheran blood group) |
chr6_-_144329384 | 0.99 |
ENST00000417959.2
|
PLAGL1
|
pleiomorphic adenoma gene-like 1 |
chr16_-_67217844 | 0.98 |
ENST00000563902.1
ENST00000561621.1 ENST00000290881.7 |
KIAA0895L
|
KIAA0895-like |
chr21_+_33784670 | 0.98 |
ENST00000300255.2
|
EVA1C
|
eva-1 homolog C (C. elegans) |
chr11_-_1912084 | 0.97 |
ENST00000391480.1
|
C11orf89
|
chromosome 11 open reading frame 89 |
chr7_-_47621229 | 0.96 |
ENST00000434451.1
|
TNS3
|
tensin 3 |
chr5_-_179780312 | 0.95 |
ENST00000253778.8
|
GFPT2
|
glutamine-fructose-6-phosphate transaminase 2 |
chr12_-_53228079 | 0.93 |
ENST00000330553.5
|
KRT79
|
keratin 79 |
chr5_+_52285144 | 0.91 |
ENST00000296585.5
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
chr22_+_31892373 | 0.90 |
ENST00000443011.1
ENST00000400289.1 ENST00000444859.1 ENST00000400288.2 |
SFI1
|
Sfi1 homolog, spindle assembly associated (yeast) |
chr20_-_62493217 | 0.90 |
ENST00000601296.1
|
C20ORF135
|
C20ORF135 |
chr6_-_46703092 | 0.89 |
ENST00000541026.1
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
chr7_+_115850547 | 0.88 |
ENST00000358204.4
ENST00000455989.1 ENST00000537767.1 |
TES
|
testis derived transcript (3 LIM domains) |
chr5_+_149340339 | 0.87 |
ENST00000433184.1
|
SLC26A2
|
solute carrier family 26 (anion exchanger), member 2 |
chr19_+_11457232 | 0.87 |
ENST00000587531.1
|
CCDC159
|
coiled-coil domain containing 159 |
chr3_+_46921732 | 0.86 |
ENST00000418619.1
|
PTH1R
|
parathyroid hormone 1 receptor |
chr9_+_1051481 | 0.84 |
ENST00000358146.2
ENST00000259622.6 |
DMRT2
|
doublesex and mab-3 related transcription factor 2 |
chr8_+_19536083 | 0.84 |
ENST00000519803.1
|
RP11-1105O14.1
|
RP11-1105O14.1 |
chr22_+_50354104 | 0.84 |
ENST00000360612.4
|
PIM3
|
pim-3 oncogene |
chr20_-_590944 | 0.84 |
ENST00000246080.3
|
TCF15
|
transcription factor 15 (basic helix-loop-helix) |
chr17_+_45286387 | 0.83 |
ENST00000572316.1
ENST00000354968.1 ENST00000576874.1 ENST00000536623.2 |
MYL4
|
myosin, light chain 4, alkali; atrial, embryonic |
chr3_-_46735155 | 0.83 |
ENST00000318962.4
|
ALS2CL
|
ALS2 C-terminal like |
chr6_-_31138439 | 0.82 |
ENST00000259915.8
|
POU5F1
|
POU class 5 homeobox 1 |
chr3_-_46735132 | 0.79 |
ENST00000415953.1
|
ALS2CL
|
ALS2 C-terminal like |
chr2_-_70944855 | 0.77 |
ENST00000415348.1
|
ADD2
|
adducin 2 (beta) |
chr12_+_53491220 | 0.75 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
chr5_-_171881491 | 0.75 |
ENST00000311601.5
|
SH3PXD2B
|
SH3 and PX domains 2B |
chr10_-_5541525 | 0.74 |
ENST00000380332.3
|
CALML5
|
calmodulin-like 5 |
chr2_-_128399706 | 0.72 |
ENST00000426981.1
|
LIMS2
|
LIM and senescent cell antigen-like domains 2 |
chr14_-_25103388 | 0.72 |
ENST00000526004.1
ENST00000415355.3 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr7_+_4815238 | 0.71 |
ENST00000348624.4
ENST00000401897.1 |
AP5Z1
|
adaptor-related protein complex 5, zeta 1 subunit |
chr2_-_43823119 | 0.71 |
ENST00000403856.1
ENST00000404790.1 ENST00000405975.2 ENST00000415080.2 |
THADA
|
thyroid adenoma associated |
chr4_+_129349188 | 0.70 |
ENST00000511497.1
|
RP11-420A23.1
|
RP11-420A23.1 |
chr11_+_73019282 | 0.68 |
ENST00000263674.3
|
ARHGEF17
|
Rho guanine nucleotide exchange factor (GEF) 17 |
chr6_+_52285046 | 0.68 |
ENST00000371068.5
|
EFHC1
|
EF-hand domain (C-terminal) containing 1 |
chr22_+_20105259 | 0.67 |
ENST00000416427.1
ENST00000421656.1 ENST00000423859.1 ENST00000418705.2 |
RANBP1
|
RAN binding protein 1 |
chr11_-_57148619 | 0.66 |
ENST00000287143.2
|
PRG3
|
proteoglycan 3 |
chr14_-_106066376 | 0.66 |
ENST00000412518.1
ENST00000428654.1 ENST00000427543.1 ENST00000420153.1 ENST00000577108.1 ENST00000576077.1 |
AL928742.12
IGHE
|
AL928742.12 immunoglobulin heavy constant epsilon |
chr1_-_117021430 | 0.66 |
ENST00000423907.1
ENST00000434879.1 ENST00000443219.1 |
RP4-655J12.4
|
RP4-655J12.4 |
chr10_-_101380121 | 0.65 |
ENST00000370495.4
|
SLC25A28
|
solute carrier family 25 (mitochondrial iron transporter), member 28 |
chr14_+_45553296 | 0.65 |
ENST00000355765.6
ENST00000553605.1 |
PRPF39
|
pre-mRNA processing factor 39 |
chr6_-_167275991 | 0.65 |
ENST00000510118.1
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
chr17_+_36861735 | 0.62 |
ENST00000378137.5
ENST00000325718.7 |
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
chr19_+_19496624 | 0.62 |
ENST00000494516.2
ENST00000360315.3 ENST00000252577.5 |
GATAD2A
|
GATA zinc finger domain containing 2A |
chr2_-_43823093 | 0.61 |
ENST00000405006.4
|
THADA
|
thyroid adenoma associated |
chr4_+_156588350 | 0.60 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr14_-_88200641 | 0.60 |
ENST00000556168.1
|
RP11-1152H15.1
|
RP11-1152H15.1 |
chr17_+_45286706 | 0.58 |
ENST00000393450.1
ENST00000572303.1 |
MYL4
|
myosin, light chain 4, alkali; atrial, embryonic |
chr20_-_32274179 | 0.56 |
ENST00000343380.5
|
E2F1
|
E2F transcription factor 1 |
chr6_-_29600832 | 0.55 |
ENST00000377016.4
ENST00000376977.3 ENST00000377034.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr19_+_19496728 | 0.54 |
ENST00000537887.1
ENST00000417582.2 |
GATAD2A
|
GATA zinc finger domain containing 2A |
chr4_-_2264015 | 0.53 |
ENST00000337190.2
|
MXD4
|
MAX dimerization protein 4 |
chr14_+_61654271 | 0.53 |
ENST00000555185.1
ENST00000557294.1 ENST00000556778.1 |
PRKCH
|
protein kinase C, eta |
chr9_+_132094579 | 0.53 |
ENST00000427109.1
|
RP11-65J3.1
|
RP11-65J3.1 |
chr11_+_101918153 | 0.52 |
ENST00000434758.2
ENST00000526781.1 ENST00000534360.1 |
C11orf70
|
chromosome 11 open reading frame 70 |
chr11_-_7904464 | 0.51 |
ENST00000502624.2
ENST00000527565.1 |
RP11-35J10.5
|
RP11-35J10.5 |
chr17_+_19282064 | 0.51 |
ENST00000603493.1
|
MAPK7
|
mitogen-activated protein kinase 7 |
chr5_-_159797627 | 0.51 |
ENST00000393975.3
|
C1QTNF2
|
C1q and tumor necrosis factor related protein 2 |
chr6_+_116937636 | 0.49 |
ENST00000368581.4
ENST00000229554.5 ENST00000368580.4 |
RSPH4A
|
radial spoke head 4 homolog A (Chlamydomonas) |
chr12_-_49582593 | 0.49 |
ENST00000295766.5
|
TUBA1A
|
tubulin, alpha 1a |
chr7_+_99746514 | 0.47 |
ENST00000341942.5
ENST00000441173.1 |
LAMTOR4
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 |
chr8_+_27182862 | 0.46 |
ENST00000521164.1
ENST00000346049.5 |
PTK2B
|
protein tyrosine kinase 2 beta |
chr7_+_12727250 | 0.46 |
ENST00000404894.1
|
ARL4A
|
ADP-ribosylation factor-like 4A |
chr1_-_1356628 | 0.45 |
ENST00000442470.1
ENST00000537107.1 |
ANKRD65
|
ankyrin repeat domain 65 |
chr9_-_131486367 | 0.45 |
ENST00000372663.4
ENST00000406904.2 ENST00000452105.1 ENST00000372672.2 ENST00000372667.5 |
ZDHHC12
|
zinc finger, DHHC-type containing 12 |
chr17_-_15168624 | 0.45 |
ENST00000312280.3
ENST00000494511.1 ENST00000580584.1 |
PMP22
|
peripheral myelin protein 22 |
chr8_-_101734308 | 0.43 |
ENST00000519004.1
ENST00000519363.1 ENST00000520142.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
chr7_+_72742178 | 0.43 |
ENST00000442793.1
ENST00000413573.2 ENST00000252037.4 |
FKBP6
|
FK506 binding protein 6, 36kDa |
chr2_+_220071490 | 0.43 |
ENST00000409206.1
ENST00000409594.1 ENST00000289528.5 ENST00000422255.1 ENST00000409412.1 ENST00000409097.1 ENST00000409336.1 ENST00000409217.1 ENST00000409319.1 ENST00000444522.2 |
ZFAND2B
|
zinc finger, AN1-type domain 2B |
chr20_-_62587735 | 0.43 |
ENST00000354216.6
ENST00000369892.3 ENST00000358711.3 |
UCKL1
|
uridine-cytidine kinase 1-like 1 |
chr19_+_37407212 | 0.42 |
ENST00000427117.1
ENST00000587130.1 ENST00000333987.7 ENST00000415168.1 ENST00000444991.1 |
ZNF568
|
zinc finger protein 568 |
chr8_-_93029865 | 0.42 |
ENST00000422361.2
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr1_-_54637997 | 0.41 |
ENST00000536061.1
|
AL357673.1
|
CDNA: FLJ21031 fis, clone CAE07336; HCG1780521; Uncharacterized protein |
chr19_-_50370799 | 0.40 |
ENST00000600910.1
ENST00000322344.3 ENST00000600573.1 |
PNKP
|
polynucleotide kinase 3'-phosphatase |
chr16_+_1662326 | 0.40 |
ENST00000397412.3
|
CRAMP1L
|
Crm, cramped-like (Drosophila) |
chr12_-_49259643 | 0.39 |
ENST00000309739.5
|
RND1
|
Rho family GTPase 1 |
chr4_+_144303093 | 0.38 |
ENST00000505913.1
|
GAB1
|
GRB2-associated binding protein 1 |
chr12_-_121019165 | 0.38 |
ENST00000341039.2
ENST00000357500.4 |
POP5
|
processing of precursor 5, ribonuclease P/MRP subunit (S. cerevisiae) |
chr19_+_38397839 | 0.38 |
ENST00000222345.6
|
SIPA1L3
|
signal-induced proliferation-associated 1 like 3 |
chr21_+_38445539 | 0.36 |
ENST00000418766.1
ENST00000450533.1 ENST00000438055.1 ENST00000355666.1 ENST00000540756.1 ENST00000399010.1 |
TTC3
|
tetratricopeptide repeat domain 3 |
chr21_-_38445443 | 0.36 |
ENST00000360525.4
|
PIGP
|
phosphatidylinositol glycan anchor biosynthesis, class P |
chr6_-_41888843 | 0.35 |
ENST00000434077.1
ENST00000409312.1 |
MED20
|
mediator complex subunit 20 |
chr3_+_9944303 | 0.35 |
ENST00000421412.1
ENST00000295980.3 |
IL17RE
|
interleukin 17 receptor E |
chr6_+_52285131 | 0.34 |
ENST00000433625.2
|
EFHC1
|
EF-hand domain (C-terminal) containing 1 |
chr6_-_83775442 | 0.34 |
ENST00000369745.5
|
UBE3D
|
ubiquitin protein ligase E3D |
chr1_+_47799446 | 0.33 |
ENST00000371873.5
|
CMPK1
|
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic |
chr5_-_122759032 | 0.32 |
ENST00000510582.3
ENST00000328236.5 ENST00000306481.6 ENST00000508442.2 ENST00000395431.2 |
CEP120
|
centrosomal protein 120kDa |
chr8_-_101963482 | 0.31 |
ENST00000419477.2
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr13_+_108870714 | 0.31 |
ENST00000375898.3
|
ABHD13
|
abhydrolase domain containing 13 |
chr19_-_36004543 | 0.30 |
ENST00000339686.3
ENST00000447113.2 ENST00000440396.1 |
DMKN
|
dermokine |
chr8_-_101734170 | 0.30 |
ENST00000522387.1
ENST00000518196.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
chr1_+_3614591 | 0.30 |
ENST00000378290.4
|
TP73
|
tumor protein p73 |
chr1_-_17216143 | 0.28 |
ENST00000457075.1
|
RP11-108M9.4
|
RP11-108M9.4 |
chr16_+_56659687 | 0.28 |
ENST00000568293.1
ENST00000330439.6 |
MT1E
|
metallothionein 1E |
chr12_-_121476750 | 0.28 |
ENST00000543677.1
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr6_-_41888814 | 0.28 |
ENST00000409060.1
ENST00000265350.4 |
MED20
|
mediator complex subunit 20 |
chr3_-_196695733 | 0.27 |
ENST00000443835.1
|
PIGZ
|
phosphatidylinositol glycan anchor biosynthesis, class Z |
chr18_-_70535177 | 0.26 |
ENST00000327305.6
|
NETO1
|
neuropilin (NRP) and tolloid (TLL)-like 1 |
chr5_-_159546396 | 0.26 |
ENST00000523662.1
ENST00000456329.3 ENST00000307063.7 |
PWWP2A
|
PWWP domain containing 2A |
chr19_+_19431490 | 0.25 |
ENST00000392313.6
ENST00000262815.8 ENST00000609122.1 |
MAU2
|
MAU2 sister chromatid cohesion factor |
chr16_+_23847355 | 0.25 |
ENST00000498058.1
|
PRKCB
|
protein kinase C, beta |
chr8_+_146277764 | 0.25 |
ENST00000331434.6
|
C8orf33
|
chromosome 8 open reading frame 33 |
chr9_+_37120536 | 0.25 |
ENST00000336755.5
ENST00000534928.1 ENST00000322831.6 |
ZCCHC7
|
zinc finger, CCHC domain containing 7 |
chr19_-_50370509 | 0.25 |
ENST00000596014.1
|
PNKP
|
polynucleotide kinase 3'-phosphatase |
chr2_+_208576259 | 0.24 |
ENST00000392209.3
|
CCNYL1
|
cyclin Y-like 1 |
chr5_-_122758994 | 0.24 |
ENST00000306467.5
ENST00000515110.1 |
CEP120
|
centrosomal protein 120kDa |
chr2_+_208576355 | 0.24 |
ENST00000420822.1
ENST00000295414.3 ENST00000339882.5 |
CCNYL1
|
cyclin Y-like 1 |
chr12_-_51785393 | 0.23 |
ENST00000605138.1
ENST00000604381.1 ENST00000605055.1 ENST00000605617.1 |
GALNT6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
chr6_-_44400720 | 0.22 |
ENST00000595057.1
|
AL133262.1
|
AL133262.1 |
chr16_+_19421803 | 0.21 |
ENST00000541464.1
|
TMC5
|
transmembrane channel-like 5 |
chr2_-_160654745 | 0.21 |
ENST00000259053.4
ENST00000429078.2 |
CD302
|
CD302 molecule |
chr17_-_36906058 | 0.21 |
ENST00000580830.1
|
PCGF2
|
polycomb group ring finger 2 |
chr9_+_37079968 | 0.21 |
ENST00000588403.1
|
RP11-220I1.1
|
RP11-220I1.1 |
chr6_+_43739697 | 0.21 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
chr19_-_14201507 | 0.21 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr12_+_131438443 | 0.21 |
ENST00000261654.5
|
GPR133
|
G protein-coupled receptor 133 |
chr4_+_175204818 | 0.20 |
ENST00000503780.1
|
CEP44
|
centrosomal protein 44kDa |
chr19_+_46498704 | 0.20 |
ENST00000595358.1
ENST00000594672.1 ENST00000536603.1 |
CCDC61
|
coiled-coil domain containing 61 |
chr20_+_35807512 | 0.19 |
ENST00000373622.5
|
RPN2
|
ribophorin II |
chr7_+_1022973 | 0.19 |
ENST00000340150.6
|
CYP2W1
|
cytochrome P450, family 2, subfamily W, polypeptide 1 |
chr6_-_83775489 | 0.19 |
ENST00000369747.3
|
UBE3D
|
ubiquitin protein ligase E3D |
chr20_+_35807449 | 0.18 |
ENST00000237530.6
|
RPN2
|
ribophorin II |
chr12_+_123717967 | 0.18 |
ENST00000536130.1
ENST00000546132.1 |
C12orf65
|
chromosome 12 open reading frame 65 |
chr14_-_57197224 | 0.18 |
ENST00000554597.1
ENST00000556696.1 |
RP11-1085N6.3
|
Uncharacterized protein |
chr18_-_18691739 | 0.17 |
ENST00000399799.2
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1 |
chr15_-_82824843 | 0.17 |
ENST00000560826.1
ENST00000559187.1 ENST00000330339.7 |
RPS17
|
ribosomal protein S17 |
chr1_-_165738085 | 0.17 |
ENST00000464650.1
ENST00000392129.6 |
TMCO1
|
transmembrane and coiled-coil domains 1 |
chr11_+_71249071 | 0.16 |
ENST00000398534.3
|
KRTAP5-8
|
keratin associated protein 5-8 |
chr20_+_35807714 | 0.16 |
ENST00000373632.4
|
RPN2
|
ribophorin II |
chr4_+_160203650 | 0.16 |
ENST00000514565.1
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2 |
chr18_+_44497455 | 0.16 |
ENST00000592005.1
|
KATNAL2
|
katanin p60 subunit A-like 2 |
chr12_+_54379569 | 0.15 |
ENST00000513209.1
|
RP11-834C11.12
|
RP11-834C11.12 |
chr16_-_30134441 | 0.14 |
ENST00000395200.1
|
MAPK3
|
mitogen-activated protein kinase 3 |
chr6_+_56819773 | 0.14 |
ENST00000370750.2
|
BEND6
|
BEN domain containing 6 |
chrX_+_118602363 | 0.13 |
ENST00000317881.8
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
chr3_+_148415571 | 0.13 |
ENST00000497524.1
ENST00000349243.3 ENST00000542281.1 ENST00000418473.2 ENST00000404754.2 |
AGTR1
|
angiotensin II receptor, type 1 |
chr4_+_15683369 | 0.13 |
ENST00000503617.1
|
FAM200B
|
family with sequence similarity 200, member B |
chr2_-_214017151 | 0.13 |
ENST00000452786.1
|
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr7_-_112758665 | 0.13 |
ENST00000397764.3
|
LINC00998
|
long intergenic non-protein coding RNA 998 |
chr18_+_56892724 | 0.13 |
ENST00000456142.3
ENST00000530323.1 |
GRP
|
gastrin-releasing peptide |
chr1_+_47799542 | 0.12 |
ENST00000471289.2
ENST00000450808.2 |
CMPK1
|
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic |
chr4_+_15683404 | 0.11 |
ENST00000422728.2
|
FAM200B
|
family with sequence similarity 200, member B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.6 | 1.9 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.5 | 2.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.5 | 2.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.4 | 2.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 8.8 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.3 | 1.3 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.3 | 55.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 0.9 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.3 | 0.8 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 1.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 53.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 1.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.7 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.2 | 0.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.2 | 0.6 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.2 | 1.1 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 1.9 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.2 | 4.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.6 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.2 | 0.5 | GO:0070377 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.2 | 1.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 3.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 2.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.8 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.6 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 2.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.7 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.5 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.1 | 0.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.2 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.1 | 1.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.3 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.1 | 1.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.5 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.4 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.4 | GO:0044211 | CTP salvage(GO:0044211) |
0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.0 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 1.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 2.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 1.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.3 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.0 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.5 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.0 | 0.2 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.0 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 1.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.3 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 1.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 6.1 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 1.0 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 5.8 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 1.0 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.0 | 0.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 5.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 10.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 0.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.5 | GO:0001534 | radial spoke(GO:0001534) |
0.2 | 0.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 4.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 29.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.5 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.6 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 3.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 2.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 1.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 59.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.2 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.1 | GO:0008021 | synaptic vesicle(GO:0008021) exocytic vesicle(GO:0070382) |
0.0 | 0.8 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 2.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0005174 | CD40 receptor binding(GO:0005174) |
1.4 | 5.5 | GO:0017129 | triglyceride binding(GO:0017129) |
0.7 | 2.1 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.4 | 99.9 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 1.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 2.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 3.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 1.4 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.2 | 4.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.6 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.2 | 1.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.2 | 0.6 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 1.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 1.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 1.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 1.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.3 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.1 | 1.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 2.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.0 | 1.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 1.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 2.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.0 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.0 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 6.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 3.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 3.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 3.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 2.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 3.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 2.8 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 1.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 3.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 4.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 2.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 1.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 2.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 1.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |